Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation

References

• Martindale (2002). The complete drug reference. In: Sweetman SC, ed. (2002). Martindale: The complete drug reference, thirty-fifth edition, London: Pharmaceutical Press, 1235–7.
   Google Scholar
• Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P. (2004). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmacol, 57, 287–94.
   Web of Science ®Google Scholar
• Chien YW. (1992). Nasal drug delivery systems. In: Swacbrick, J, ed. Novel drug delivery systems. New York: Marcel Dekker, 139–96.
   Google Scholar
• Zaki NM, Award GA, Mortada ND, Elhady SS. (2006). Rapid onset intranasal delivery of metoclopramide hydrochloride. Part II: safety of various absorption enhancers and pharmacokinetic evaluation. Int J Pharm, 327, 97–103.
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Vavia PR. (2004). The influence of absorption enhancers on nasal absorption of acyclovir. Eur J Pharm Biopharm, 57, 483–7.
   PubMed Web of Science ®Google Scholar
• Dondeti P, Zia H, Needham TE. (1996). Bioadhesive and formulation parameters affecting nasal absorption. Int J Pharm, 127, 115–33.
   Web of Science ®Google Scholar
• Merkus FWHM, Verhoef JC, Marttin E, Romeijn SG, Van der Kuy PHM, Hermens WAJJ, Schipper NGM. (1999). Cyclodextrins in nasal drug delivery. Adv Drug Del Rev, 36, 41–57.
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Agu RU, Vanbilloen H, Baetens J, Augustijns P, Verbeke N, Mortelmans L, Verbruggen A, Kinget R, Bormans G. (2000). Scintigraphic evaluation in rabbits of nasal drug delivery systems based on carbopol 971p® and carboxymethylcellulose. J Contr Rel, 6, 207–14.
   Google Scholar
• Tas C, Ozkan Y, Savas¸er A, Baykara T. (2003). In vitro release studies of chlorpheniramine maleate gels prepared by different cellulose derivatives. II Farmaco, 58, 605–11.
   PubMedGoogle Scholar
• Osth K, Paulsson M, Björk E, Edsman K. (2002). Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber. J Contr Rel, 83, 377–88.
   PubMed Web of Science ®Google Scholar
• Cheng Y-H, Watts P, Hinchcliffe M, Hotchkiss R, Nankervis R, Faraj NF, Smith A, Davis SS, Illum L. (2002). Development of a nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. J Contr Rel, 79, 243–54.
   PubMed Web of Science ®Google Scholar
• Shargel L, Yu ABC. (1985). Applied biopharmaceutics and pharmacokinetics, 2nd ed. Norwalk: Appleton-Century-Crofts, 231–43.
   Google Scholar
• Tas C, Ozkan CK, Savaser A, Ozkan Y, Tasdemir U, Altunay H. (2006). Nasal absorption of metoclopramide from different carbopol® 981 based formulations: in vitro, ex vivo and in vivo evaluation. Eur J Pharm Biopharm, 64, 246–54.
   PubMed Web of Science ®Google Scholar
• Escudero JJ, Ferrero C, Jimenez-Castellanos MR. (2008). Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades. Int J Pharm, 351, 61–73.
   PubMed Web of Science ®Google Scholar
• Ma WD, Xu H, Wang C, Nie S-F, Pan W-S. (2008). Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for opthalmic drug delivery system. Int J Pharm, 350, 247–56.
   PubMed Web of Science ®Google Scholar
• Rajinikanth PS, Mishra B. (2008). Floating in situ gelling system for stomach site-spesific delivery of claritromycin to eradicate H.pylori. J Contr Rel, 125, 33–41.
   PubMed Web of Science ®Google Scholar
• Fang J-Y, Hwang T-L, Leu Y-L. (2003). Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm, 250, 313–25.
   PubMed Web of Science ®Google Scholar
• D’Souza R, Mutalik S, Venkatesh M, Vidyasagar S, Udupa N. (2005). Nasal insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies. AAPS Pharm Sci Tech, 6, 184–9.
   PubMed Web of Science ®Google Scholar
• Charlton ST, Davis SS, Illum L. (2007). Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies. J Contr Rel, 118, 225–34.
   PubMed Web of Science ®Google Scholar
• Mahato RI. (2004). Pharmaceutical delivery systems and dosage forms. New York: Castle Connoly, 37–64.
   Google Scholar
• Zhang Y, Zhang Q, Sun Y, Sun J, Wang X, Chen M. (2005). Nasal recombinant hirudin-2 delivery: absorption and its mechanism in vivo and in vitro studies. Bio Pharm Bull, 28, 2263–7.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Awad GA, Mortada ND, Elhady SSA. (2007). Enhanced bioavailability of metoclopramide HCI by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci, 32, 296–307.
   PubMed Web of Science ®Google Scholar
• Behl CR, Pimplaskar HK, Sileno AP, deMeireles J, Romeo VD. (1998). Effects of physicochemical and other factors on systemic nasal drug delivery. Adv Drug Del Rev, 29, 89–116.
   PubMed Web of Science ®Google Scholar
• Aurora J. (2002). Development of nasal delivery systems. A Review. Drug Deliv Technol, 2(7), 70–3.
   Google Scholar
• Martin E, Romeijn SG, Verhoef JC, Merkus FWHM. (1997). Nasal absorption of dihydroergotamine from liquid and powder forrmulations in rabbits. J Pharm Sci, 86, 802–7.
   PubMed Web of Science ®Google Scholar
• Asai K, Morishita M, Katsuta H, Hosoda S, Shinomiya K, Noro M, Nagai T, Takayama K. (2002). The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int J Pharm, 246, 25–35.
   PubMed Web of Science ®Google Scholar
• Arora P, Sharma S, Garg S. (2002). Permeability issues in nasal drug delivery. Drug Discov Today, 7, 967–75.
   PubMed Web of Science ®Google Scholar
• Najafabadi AR, Moslemi P, Tajerzadeh H. (2004). Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits. Drug Del, 11, 295–300.
   PubMed Web of Science ®Google Scholar
• Morimoto K, Tabata H, Morisaka K. (1987). Nasal absorption of nifedipine from gel preparations in rats. Chem Pharm Bull, 35, 3041–4.
   PubMed Web of Science ®Google Scholar
• Tuncel T, Otuk G, Kuscu I, Ates S. (1994). Nasal absorption of roxitromycin from gel preparations in rabbits. Eur J Pharm Biopharm, 40, 24–6.
   Web of Science ®Google Scholar
• Yetkin G, çelebi N, Agabeyoglu I, Gokcora N. (1999). The effect of dimethyl-β-cyclodextrin and sodium taurocholate on the nasal bioavailability of salmon calcitonin in rabbits. STP Pharm Sci, 9, 249–52.
   Google Scholar
• Ozsoy Y, Tuncel T, Can A, Akev N, Birteksoz S, Gerceker A. (2000). In vivo nasal studies on nasal preparations of ciprofloxacin hydrochloride. Pharmazie, 55, 607–9.
   PubMed Web of Science ®Google Scholar
• Leitner VM, Guggi D, Bernkop-Schnurch A. (2004). Thiomers in noninvasive poypeptide delivery: in vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone. J Pharm Sci, 93, 1682–91.
   PubMed Web of Science ®Google Scholar
• Ishikawa F, Katsura M, Tamai I, Tsuji A. (2001). Improved nasal bioavailability of elcatonin by insoluble powder formulation. Int J Pharm, 224, 105–14.
   PubMed Web of Science ®Google Scholar
• Leitner VM, Guggi D, Krauland AH, Bernkop-Schnürch A. (2004). Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J Contr Rel, 100, 87–95.
   PubMed Web of Science ®Google Scholar
• Ugwoke MI, Exaud S, Mooter GVD, Verbeke N, Kinget R. (1999). Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits. Eur J Pharm Sci, 9, 213–9.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Maitani Y, Takayama K. (2002). The enhancing effect of nasal absorption of FITC-Dextran 4,400 by β-Sitosterol β-D-Glucoside in rabbits. J Contr Rel, 79, 147–55.
   PubMed Web of Science ®Google Scholar
• Gu F, Cui F, Gao Y. (2005). Preparation of prostaglandin E1-hydroxypropyl-β-cyclodextrin complex and its nasal delivery in rats. Int J Pharm, 290, 101–8.
   PubMed Web of Science ®Google Scholar
• Irie T, Wakamatsu K, Arima H, Aritomi H, Uekama K. (1992). Enhancing effects of cyclodextrins on nasal absorption of insulin in rats. Int J Pharm, 84, 129–39.
   Web of Science ®Google Scholar
• Sinswat P, Temgamnuay P. (2003). Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-β-cyclodextrins. Int J Pharm, 257, 15–22.
   PubMed Web of Science ®Google Scholar
• Yang T, Hussain A, Paulson J, Abbruscato TJ, Ahsan F. (2004). Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies. Pharm Res, 21, 1127–36.
   PubMed Web of Science ®Google Scholar